We propose that through advancing our understanding on the potential mechanism(s) by which HMGB1 functions in the context of limiting CNS remyelination, we may exploit this knowledge as a novel means to stimulate endogenous remyelination in the MS brain. This evidence concerns the gene HMGB1 and myeloid sarcoma.